Search Results

Whitman-Walker Institute, Cancer Support Community, and GRAIL, LLC announced a research collaboration aimed at advancing health equity in cancer screening and care with GalleriⓇ, a multi-cancer early detection test, in diverse patient populations.

Avantor, Inc. announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield.

Zentalis® Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, announced the appointment of Luke Walker, M.D., to its Board of Directors.

Applied DNA Sciences, Inc. announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC, will utilize the GenXys Health Care Systems suite of clinical decision support software for interpretation and reporting of ADCL’s New York State Department of Health-approved TR8™ pharmacogenomic test.

Paradigm announced results from a collaboration with Altru Health System (Altru) to improve the efficiency of its clinical research program and expand the availability of clinical research as a care option for patients spanning 46 locations across a rural catchment area of over 4,000 square miles in North Dakota and Minnesota.

Inspire Medical Systems, Inc. announced that its management team will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024.

Axena Health, Inc., a medical device company focused on female pelvic health, welcomes the Centers for Medicare & Medicaid Services’ new Healthcare Common Procedure Coding System Level II code for the Leva® Pelvic Health System.